Back to results
US 8,618,311 B2Granted
Synthetic processes for the preparation of aminocyclohexyl ether compounds
AssigneeCardiome Pharma Corp.
InventorsGrace Jung, James Gee Ken Yee, Doug Ta Hung Chou, Bertrand M. C. Plouvier
Life of this patent
Estimating the term…
Abstract
This invention is directed to stereoselective synthesis of compounds of formula (I) or formula (II): or a pharmaceutically acceptable salt, ester, amide, complex, chelate, clathrate, solvate, polymorph, stereoisomer, metabolite or prodrug thereof; wherein R3, R4 and R5 are defined herein. Compounds of formula (I) and formula (II) are known to be useful in treating arrhythmias.
Claims9
A method of making a compound of formula (I):
- or a pharmaceutically acceptable salt thereof, as a single stereoisomer or as a mixture thereof;
- wherein:
- R3, R4 and R5 are independently bromine, chlorine, fluorine, carboxy, hydrogen, hydroxy, hydroxymethyl, methanesulfonamido, nitro, cyano, sulfamyl, trifluoromethyl, —CHF2, —SO2N(R8)R9, —OCF3, C2-C7alkanoyloxy, C1-C6alkyl, C1-C6alkoxy, C7-C12aralkoxy, C2-C7alkoxycarbonyl, C1-C6thioalkyl, aryl or —N(R6)R7;
- and
- R6, R7, R8, and R9 are each independently selected from hydrogen, acetyl, methanesulfonyl or C1-C6alkyl;
- which method comprises:
- a) a nucleophilic displacement step comprising treating a compound of formula (16):
- wherein —OR′ is an activated leaving group and R3, R4 and R5 are as defined above, with an azide under suitable nucleophilic displacement conditions and subsequent reduction conditions to form a compound of formula (17):
- wherein R3, R4 and R5 are as defined above;
- b) reacting the compound of formula (17):
- wherein R3, R4 and R5 are as defined above, with a compound of formula (2a2):
- wherein R is H, C2-C5acyl or an oxygen-protecting group, under suitable condensation conditions to form a compound of formula (6b):
- wherein R is H, C2-C5acyl or an oxygen-protecting group and R3, R4 and R5 are as defined above;
- and
- c) reducing the compound of formula (6b) under suitable conditions to form a compound of formula (I), as set forth above;
- and
- d) optionally forming the pharmaceutically acceptable salt of the compound of formula (I) under suitable conditions.
14 more elements
Dependencies are inferred from the claim text.